• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 22
  • 8
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1

PRICE

2
3
32
41

PUBLISHED

0
4
24
41

PRODUCT TYPE

39
2

Search "ProMetic Life Sciences Inc.-Therapeutic Competitors Report" returned 41 results.

Cardiac Fibrosis - Pipeline Review, H1 2015

Cardiac Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Cardiac Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Cardiac Fibrosis’s therapeutic pipeline. This report provides...

May 2015
FROM

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014 Summary This, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2014’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic...

September 2014
FROM

Hyperlipidemia - Pipeline Review, H2 2014

Hyperlipidemia - Pipeline Review, H2 2014 Summary This, ‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Liver Fibrosis - Pipeline Review, H2 2014

Liver Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Liver Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Liver Fibrosis - Pipeline Review, H1 2014

Liver Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Liver Fibrosis’s therapeutic pipeline. This report...

April 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2014

Chemotherapy Induced Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy Induced Anemia’s...

March 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Chemotherapy Induced Anemia - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

February 2015
FROM

Liver Fibrosis - Pipeline Review, H1 2015

Liver Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Liver fibrosis - Pipeline Review, H1 2015’, provides an overview of the Liver fibrosis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Kidney Fibrosis - Pipeline Review, H1 2015

Kidney Fibrosis - Pipeline Review, H1 2015 Summary This, ‘Kidney Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This report provides comprehensive...

April 2015
FROM
Competitor Analysis: Erythropoietin (EPO) Competitor Analysis: Erythropoietin (EPO) - Product Thumbnail Image

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Kidney Fibrosis - Pipeline Review, H2 2014

Kidney Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Kidney Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Kidney Fibrosis - Pipeline Review, H1 2014

Kidney Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline. This...

February 2014
FROM

Neutropenia - Pipeline Review, H1 2014

Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Neutropenia’s therapeutic pipeline. This report provides...

March 2014
FROM

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014 Summary This, ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune Deficiency (PID)’s...

December 2014
FROM

Primary Immune Deficiency (PID) - Pipeline Review, H1 2015

Primary Immune Deficiency (PID) - Pipeline Review, H1 2015 Summary This, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2015’, provides an overview of the Primary Immune Deficiency (PID)’s...

April 2015
FROM

Pulmonary Fibrosis - Pipeline Review, H2 2014

Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. This report provides...

December 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

August 2014
FROM

Diabetic Nephropathy - Pipeline Review, H1 2015

Diabetic Nephropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline. This report...

January 2015
FROM

Prostate Cancer - Pipeline Review, H2 2014

Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Renal Anemia - Pipeline Review, H2 2014

Renal Anemia - Pipeline Review, H2 2014 Summary This, ‘Renal Anemia - Pipeline Review, H2 2014’, provides an overview of the Renal Anemia’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM
Loading Indicator

Our Clients

Hewlett-Packard Company Microsoft Corporation Philips N.V. SONY Corporation Cypress Semiconductor Corporation Panasonic Corporation